Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B. Phillip Donenberg


  • Director at Avrobio Inc. (AVRO), 2019-06-13
  • Svp And Cfo at Depomed Inc (DEPO), 2018-07-16
  • Chief Financial Officer at Avexis Inc. (AVXS), 2018-05-15
  • Director at Restorgenex Corp (RESX), 2014-07-29
  • Sr Vp Of Finance, Cfo, Secy at Biosante Pharmaceuticals Inc (BPAX), 2012-01-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPAX $2.23 1,000 Officer 44,322 2011-08-08 Filing
BPAX $2.19 1,000 Officer 43,322 2011-08-05 Filing
BPAX $1.88 1,000 Officer 42,322 2011-01-21 Filing
BPAX $1.88 1,000 Officer 41,322 2011-01-19 Filing
BPAX $1.00 3,000 Officer 40,322 2008-12-31 Filing